A marrow donor is not needed
The early transplant-related death rate is low due to the lack of “graft-versus-host” disease, due to the low incidence of interstitial pneumonitis, and due to the fact that there is no rejection of the graft.
KeywordsToxicity Europe Lymphoma Leukemia Interferon
Unable to display preview. Download preview PDF.
- Bensinger WI, Berenson RJ, Andrews RG, et al (1988) Proceedings of XIVth Annual Meeting of the European Cooperative Group for Bone Marrow Transplantation, Chamonix, France, 10–13 April 1988Google Scholar
- Fefer A (1986) Current status of syngeneic marrow transplantation and its relevance to autografting. Clin Haemtaol 15:49–65Google Scholar
- Hagenbeck A, Martens CM (1987) Conditioning regimens before bone marrow transplantation in acute myelocytic leukemia. In: Dicke KA, Spitzer G, Jagannath S (eds) Autologous bone marrow transplantation. Proceedings of the third international symposium. University of Texas MD. Anderson Hospital and Tumor Institute, Houston, pp 99–103Google Scholar